Tech billionaire Elon Musk poured cold water Wednesday on a landmark half-a-trillion dollar artificial intelligence (AI) initiative trumpeted by U.S. President Donald Trump. His criticism marks an ...

Intel Corp.’s stock is getting another boost on Tuesday, after seeing its best day on record Friday. The catalyst then was a report from SemiAccurate that discussed a mystery company said to be ...

Mr. Trump had claimed the A.I. announcement as an early trophy, taking credit for the companies’ decision to spend up to $500 billion building data centers. By Theodore Schleifer and Cecilia ...

Excalidraw is an innovative online whiteboarding tool that uses the power of artificial intelligence (AI) to convert simple text prompts into detailed, professional-quality diagrams. Whether you ...

Tower defense games span various themes and settings, keeping gameplay tense or calm. Rock of Ages 2 offers high-speed gameplay different from traditional tower defense games. Orcs Must Die! 3 ...

But with his second term quickly approaching, many U.S. adults are skeptical about his ability to bring down costs. Only about 2 in 10 Americans are “extremely” or “very” confident that Trump will be ...

The company pulled off the first booster “catch” — which involves articulated arms on the launch tower snatching the rocket stage out of the air as it uses rockets to slow its descent — in ...

Pakistan's flag carrier has drawn widespread criticism for putting out an advertisement that showed a plane flying towards the Eiffel Tower. The ad was meant to promote the resumption of Pakistan ...

(The Center Square) – The Washington State Legislature’s Republican leadership found itself at a loss for words during a Wednesday press conference following Gov. Bob Ferguson’s inaugural address.

Copyright 2025 The Associated Press. All Rights Reserved. Donald Trump’s pick for attorney general, Pam Bondi, insisted in her Senate confirmation hearing that ...

The FDA met resistance from a three-judge panel Wednesday over its decision to refuse approval of Vanda Pharmaceuticals Inc.’s jet lag disorder drug. At issue in arguments before the US Court of ...